logo

Bausch Health Companies Inc. (BHC.TO)



Trade BHC.TO now with
  Date
  Headline
10/23/2019 7:41:52 AM Bausch Health Buys License For Commercialization Of XIPERE In The United States And Canada
10/1/2019 6:58:01 AM Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN 550 Mg Tablets
9/3/2019 7:59:51 AM Bausch Health To Reduce Debt By About $200 Mln Using Cash Flow From Operations
8/7/2019 7:06:13 AM Ortho Dermatologics Unveils US FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form
8/6/2019 7:43:22 AM Bausch Health Q2 Total Reported Revenues $2.152 Bln, Increase Of $24 Mln
7/9/2019 7:01:43 AM Bausch + Lomb Announces U.S. Launch Of Ocuvite Eye Performance Vitamins
6/25/2019 8:06:30 AM Bausch Health To Reduce Debt By Addl $100 Mln Using Cash Generated From Operations
6/25/2019 7:01:02 AM Bausch Health Announces U.S. Launch Of DUOBRII Lotion 0.01%/0.045% For Plaque Psoriasis In Adults
6/19/2019 7:09:41 AM Bausch + Lomb Announces U.S. Launch Of Bausch + Lomb ULTRA Multifocal For Astigmatism Contact Lenses
5/9/2019 8:12:54 AM Bausch Health Companies Plans Private Offering Of Senior Notes
4/29/2019 8:09:04 AM Bausch + Lomb Says New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented
4/25/2019 7:17:50 AM Salix, Mitsubishi Tanabe To Develop Late Stage Investigational S1P Modulator For Inflammatory Bowel Disease
4/2/2019 7:07:38 AM Bausch + Lomb Announces U.S. Launch Of LOTEMAX SM 0.38% For Postoperative Inflammation, Pain Following Ocular Surgery
4/1/2019 7:22:47 AM Salix Pharma, California Univ. To Develop Compound For Treatment Of Non-alcoholic Fatty Liver Disease, Steatohepatitis
3/8/2019 7:03:38 AM Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers
3/6/2019 9:04:42 AM Bausch Health Closes Acquisition Of Certain Assets Of Synergy Pharma
2/26/2019 7:42:51 PM Bausch Health Selected As Successful Bidder To Buy Certain Assets Of Synergy Pharma For $195 Mln And Assumption Of Debt
2/25/2019 7:06:24 AM Bausch + Lomb Announces FDA Approval Of LOTEMAX SM 0.38% For Postoperative Inflammation And Pain
  
 
>